324 related articles for article (PubMed ID: 32299492)
41. Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis.
Hamo L; Stohlman SA; Otto-Duessel M; Bergmann CC
Glia; 2007 Aug; 55(11):1169-77. PubMed ID: 17600339
[TBL] [Abstract][Full Text] [Related]
42. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.
van der Maesen K; Hinojoza JR; Sobel RA
J Neuropathol Exp Neurol; 1999 Apr; 58(4):346-58. PubMed ID: 10218630
[TBL] [Abstract][Full Text] [Related]
43. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
44. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.
Zhu Y; Chen X; Liu Z; Peng YP; Qiu YH
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729090
[TBL] [Abstract][Full Text] [Related]
46. Borna disease virus-infected astrocytes function in vitro as antigen-presenting and target cells for virus-specific CD4-bearing lymphocytes.
Richt JA; Stitz L
Arch Virol; 1992; 124(1-2):95-109. PubMed ID: 1349208
[TBL] [Abstract][Full Text] [Related]
47. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
[TBL] [Abstract][Full Text] [Related]
48. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model.
Matsumoto T; Imagama S; Hirano K; Ohgomori T; Natori T; Kobayashi K; Muramoto A; Ishiguro N; Kadomatsu K
Neurosci Lett; 2012 Jun; 520(1):115-20. PubMed ID: 22634473
[TBL] [Abstract][Full Text] [Related]
49. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
[TBL] [Abstract][Full Text] [Related]
50. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease.
Li Y; Niu M; Zhao A; Kang W; Chen Z; Luo N; Zhou L; Zhu X; Lu L; Liu J
J Neuroinflammation; 2019 Dec; 16(1):263. PubMed ID: 31831012
[TBL] [Abstract][Full Text] [Related]
51. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
[TBL] [Abstract][Full Text] [Related]
52. Alpha-synuclein seeds of Parkinson's disease show high prion-exceeding resistance to steam sterilization.
Pinder P; Thomzig A; Schulz-Schaeffer WJ; Beekes M
J Hosp Infect; 2021 Feb; 108():25-32. PubMed ID: 33137444
[TBL] [Abstract][Full Text] [Related]
53. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
[TBL] [Abstract][Full Text] [Related]
54. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
George S; Brundin P
J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
[TBL] [Abstract][Full Text] [Related]
55. The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: potential in vivo function of Fas in experimental allergic encephalomyelitis.
Thilenius AR; Sabelko-Downes KA; Russell JH
J Immunol; 1999 Jan; 162(2):643-50. PubMed ID: 9916681
[TBL] [Abstract][Full Text] [Related]
56. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
57. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms.
Frohman EM; Vayuvegula B; Gupta S; van den Noort S
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1292-6. PubMed ID: 2829222
[TBL] [Abstract][Full Text] [Related]
58. Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model.
Lai TT; Kim YJ; Nguyen PT; Koh YH; Nguyen TT; Ma HI; Kim YE
Front Integr Neurosci; 2021; 15():715190. PubMed ID: 34675786
[TBL] [Abstract][Full Text] [Related]
59. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
[TBL] [Abstract][Full Text] [Related]
60. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions.
Matsumoto Y; Ohmori K; Fujiwara M
Immunology; 1992 Jun; 76(2):209-16. PubMed ID: 1378815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
